News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 31, 2016

Considering a Second Opinion for Cancer Care

Episodes in this series

EP. 1 Freda's Story: Her Diagnosis of CRC

EP. 1 Freda's Story: Her Diagnosis of CRC

EP. 2 Interventional Radiologist's Role

EP. 2 Interventional Radiologist's Role

EP. 3 Considering a Second Opinion for Cancer Care

EP. 3 Considering a Second Opinion for Cancer Care

EP. 4 It Takes a Team to Treat Cancer

EP. 4 It Takes a Team to Treat Cancer

EP. 5 Treatment of Metastatic Colorectal Cancer

EP. 5 Treatment of Metastatic Colorectal Cancer

EP. 6 Clinical Trials for Cancer Treatment

EP. 6 Clinical Trials for Cancer Treatment

EP. 7 Improving Care For Patients

EP. 7 Improving Care For Patients

EP. 8 Freda: Managing Aggressive Treatment

EP. 8 Freda: Managing Aggressive Treatment

EP. 9 Finding the Right Treatment Option

EP. 9 Finding the Right Treatment Option

EP. 10 How to Pay for Treatment Options

EP. 10 How to Pay for Treatment Options

Newsletter

Stay up to date on cancer updates, research and education

Related Content

"FDA" text.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

December 15th 2025

Image of Debbie.

Accepting That You Are Changed by Cancer

ByDebbie Legault

December 15th 2025

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

image of woman.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025

Trending on CURE

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia

Accepting That You Are Changed by Cancer

Cancer in the Rearview Mirror

Loqtorzi Nearly Doubles Long-Term Survival in Nasopharyngeal Cancer

© 2025 MJH Life Sciences^®

All rights reserved.